Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

In the world of health, Novo Nordisk stops insulin pen production, Trump's potential health appointments draw attention, and ...

Thursday is World Diabetes Day. Diabetes affects 40 million Americans and for most, the best form of treatment includes ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

No­vo Nordisk said Thurs­day that it plans to even­tu­al­ly halt all of its hu­man in­sulin pen pro­duc­tion glob­al­ly, ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Diabetes management has come a long way, with treatment options now as varied as they are effective. No longer limited to ...

From wearable glucose monitors to AI-driven health insights, recent advances are giving patients new ways to manage blood ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...

We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...